Health Secretary Robert F. Kennedy Jr. has introduced new initiatives aimed at reducing the prescription of selective serotonin reuptake inhibitors (SSRIs) in the U.S., promoting alternative treatments and involving clinicians more in guiding patients through discontinuation, amidst concerns of overprescription and withdrawal symptoms associated with these widely used antidepressants. #MentalHealth #Psychiatry #Overmedication #US #GB #DE
